Insider · CIK 0001879974
Neesha Hathi
Files at SCHW (SCHWAB CHARLES CORP), CI (Cigna Group). First filing Sep 2, 2026, latest Oct 5, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SCHW: SCHWAB CHARLES CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | SCHWAB CHARLES CORP | $489k 5,000 shares | -46% | +16% from low-13% from high | |
| 5Weak | SCHWAB CHARLES CORP | $346k 3,177 shares | -36% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | SCHW SCHWAB CHARLES CORP | MOption exercise Common Stock10b5-1 | +5,000 | $41.98 | $210k | 0 | 7 d ago |
| Oct 1, 2026 | SCHW SCHWAB CHARLES CORP | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -5,000 | $97.80 | $489k | 5,770 | 7 d ago |
| Oct 1, 2026 | SCHW SCHWAB CHARLES CORP | MOption exercise Nonqualified Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 13,950 | 7 d ago |
| Sep 1, 2026 | SCHW SCHWAB CHARLES CORP | MOption exercise Common Stock10b5-1 | +3,177 | $52.05 | $165k | 0 | 40 d ago |
| Sep 1, 2026 | SCHW SCHWAB CHARLES CORP | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -3,177 | $109.04 | $346k | 5,770 | 40 d ago |
| Sep 1, 2026 | SCHW SCHWAB CHARLES CORP | MOption exercise Nonqualified Stock Option (right to buy)derivative10b5-1 | -3,177 | $0.00 | $0 | 0 | 40 d ago |
| Apr 23, 2025 | CI Cigna Group | AGrant or award Common Stock, $.01 Par Value | +638 | $0.00 | $0 | 3,369 | Apr 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.